Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > All Ingredients News

Eisai to sell clinical diagnostics supply business

25-Nov-2015 - Eisai will sell its clinical diagnostics business – EIDIA Co. Ltd - to Sekisui Chemical for JPY 22.4bn ($183m).

Ash Stevens to make API for Takeda's new oral blood cancer drug

24-Nov-2015 - The US FDA has cleared Ash Stevens to make the API for Takeda's new multiple myeloma drug Ninlaro, which is the first oral proteasome inhibitor to be approved in the country.

AZ not worried about giving Sanofi a potential blockbuster in swap deal

24-Nov-2015 - AstraZeneca says it had no worries about giving rival Sanofi a potential blockbuster drug when the two exchanged compound library molecules this month. 

API sourcing leads US Gov to label Carlsbad's Acyclovir tablets as made in Asia

23-Nov-2015 - US Customs and Border Protection (CBP) says the country of origin of Carlsbad Technology’s acyclovir is where the API is sourced, not the US where the tablets are made.

Strides Shasun restarts API production at fire struck plant

23-Nov-2015 - Strides Shasun has restarted some active pharmaceutical ingredient (API) production at a plant in Cuddalore, India after a fire last week.

Pharma unhappy with French 'made in EU' proposal

19-Nov-2015 - France's government has proposed new labelling for medicines that would indicate whether the contents were manufactured in or outside Europe.

Antibiotics: urgent calls for global payment pot

17-Nov-2015 - As World Antibiotics Awareness Week draws attention to the threat of resistance, pharma companies large and small say a worldwide overhaul of payment models will make anti-infective R&D profitable again.

Government blames India's poor quality stigma on 'turf war' with West

09-Nov-2015 - The over-reaction to quality infringements by Indian drugmakers is part of a “turf war” with Western firms, the Indian Government says.

Acquisitions drive AMRI’s ambition to become a ‘billion dollar’ CDMO

09-Nov-2015 - AMRI attributed recent M&A activity to passing the $100m (€93m) quarterly sales milestone, reporting high double-digit growth across its API and small-scale manufacturing divisions.

BASF begins production at German intermediate plant

05-Nov-2015 - Production has begun at a BASF facility in Germany to help feed the growth in pharma demand for specialty amines.

Almac buys biocatalysis partner Arran, expanding capacity and services

04-Nov-2015 - Almac has acquired Arran Chemical Company to further grow its biocatalysis services and increase its large-scale intermediates capacity.

Manganese-based catalyst to offer cost-effective drug properties enhancement

04-Nov-2015 - A manganese-based catalyst invented by chemists in Illinois could transform the solubility of drug candidates and improve their therapeutic properties.

Engineered banana protein shows potential as potent antiviral

28-Oct-2015 - A team of researchers has modified a lectin protein found in bananas to diminish its inflammatory properties, potentially setting it on the path to use as an antiviral.

Pharmerging markets will be a $500bn 'game changer,' says Reva

21-Oct-2015 - ‘Pharmerging markets’ have extended beyond Brazil, Russia, India and China (BRIC) and will be worth $500bn by 2020, according to Reva Pharma.

Pay-as-you-go or unlimited access? EMD ups its risk assessment service

20-Oct-2015 - EMD Millipore will offer drugmakers two-years of unlimited access to its suite of raw materials dossiers for 20,000€ as part of its enhanced portfolio offering.

Hovione to refurbish ex-generics plant for oral and inhalable formulation site

20-Oct-2015 - Hovione will spend $10m refurbishing a plant acquired from a Portuguese generics company to create an oral and inhalation formulation site.

Dispatches from CPhI

EFCG: ‘API’ days for Europe as Big Pharma returns in search of quality

15-Oct-2015 - Big Pharma has returned to Europe for its API sourcing due to reasons of quality and reliability, according to the European Fine Chemicals Group (EFCG).

CPhI Worldwide 2015

As it happened: CPhI Pharma Awards winners announced

14-Oct-2015 -   [View the story "2015 CPhI Pharma Awards winners" on Storify]

European API makers must invest to compete with India, says Infa Group

14-Oct-2015 - Clients are turning their backs on low-cost economies like India and returning to Infa Group, the Italian API maker says.

DSM's Nutritional Products team in Spain to sell vitamin APIs to drugmakers

13-Oct-2015 - DSM may have narrowed the focus of its pharmaceutical business in recent years, but the Netherlands-based supplier is still trying to win drug industry customers at a trade show in Spain.

CPhI Worldwide 2015

If you want new excipients, regulate them, says BASF

13-Oct-2015 - A BASF expert is calling for an independent review body for new excipients to reassure wary drugmakers of their quality.

It's not easy being green, but biotechs should consider it according to Piramal

13-Oct-2015 - Pharma and biotech firms not using ‘green chemistry’ to make their products incur higher costs and risk losing market share according to Piramal.

Live coverage of CPhI

The plaza to be: Medicine manufacturers meet in Madrid

12-Oct-2015 -   [View the story "Meds makers meet in Madrid " on Storify]

Hovione: API outsourcing not only about cost

12-Oct-2015 - The cost of outsourcing is far more than simply the price per kilogram of an API says Hovione, which is expanding a plant in New Jersey.

Nisso asks Mutchler to help it communicate better with US pharma

12-Oct-2015 - Nisso Soda Co. has partnered with Mutchler Pharmaceutical Ingredients to try and win a greater share of the US hydroxypropyl cellulose market months after expanding production capacity.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...